ABSTRACT
INTRODUCTION
Genome-wide association studies (GWASs) have been successful for detecting genetic variants associated with complex diseases and traits, which usually result from interplay of multiple factors including genetic, epigenetic, transcriptomic, proteomic and/or environmental factors. The effects of genetic variants either individually or even in aggregation on complex traits are typically small to moderate at best (1) . More importantly, the vast majority of identified GWAS variants (in the order of >10 4 ) do not map to protein-encoding regions, so the underlying mechanism remain largely elusive.
Expression quantitative trait loci (eQTL) analysis which postulate mechanistic hypotheses between genetic variants and the expression levels of genes, particularly genes in the neighborhood (i.e., cis or more precisely local eQTLs) (2-7), has become an important tool for functional interpretation of GWAS. Transcriptome-wide association studies (TWAS), which identify significant expression-trait associations through correlating the imputed gene expression to the trait, enables the GWAS and eQTL datasets from two independent studies (8-10, BioRxiv: https://doi.org/10.1101/286013).
Such TWAS analyses can also be performed using summary statistic from GWAS and eQTL datasets when individual level data are not available (11) . Mancuso et al.
proposed a method of utilizing the cis genetic variation near a gene to estimate the local genetic correlation between gene expression and a complex trait in TWAS and estimate the causal relationship between pairs of complex traits that are genetically correlated (11) . Integration of genotype, gene expression and phenotype information from GWAS and eQTL datasets will fundamentally advance our knowledge of molecular mechanisms of complex disorders and quantitative traits. Several excellent review papers exist for causal relationship inference in the context of genetic mapping for complex traits (12, 13) .
The integrative genomic studies enable mechanistic interpretations, for example, via either the methods of instrumental variable(s)(IV[s]) and/or mediation analysis.
Mendelian randomization (MR) framework (14) (15) (16) has been adopted by a number of methods. MR treats genetic variant(s) (in most cases, SNPs) as the IV(s) to assess the causal effects of genetic variants through some mediator(s) of interest (e.g. expression levels of some gene [s] ) on the trait of interest (10, 15, 17) . Classic MR methods, such as SMR (10) , make several key assumptions including complete mediation, where
SNPs must be marginally independent of the confounding between mediator and final outcome, and a priori knowledge that the causal flow is from SNP to mediator but not the reverse (14, 18, 19 Another drawback of MR methods is that they cannot distinguish between mediation and pleiotropy, the phenomenon of one SNP having effect on more than one outcome (where the outcome can be either a molecular measure such as gene expression or a phenotypic outcome) ( Figure 1 ). Since pleiotropy is commonly observed for many complex traits (22) 
MATERIAL AND METHODS

multi-SNP Mediation intersection-Union Test (SMUT)
SMUT is a powerful test for the joint mediation effects of multiple genetic variants on a trait through a single mediator. The multiple genetic variants can be in a region, sublocus defined by genes, or moving windows across the genome.
Notation and Data Set-up
Without loss of generality, we assume that we have three types of data. Specifically, genes (i.e., mediators). Let = ( 1 , 2 , . . . , ) be the vector of phenotypic trait.
SMUT Model and Test for Joint Mediation Effects
SMUT models the effects of genetic variants on the trait mediated by the expression level of a single gene. We start with considering a more general model with multiple genes expression levels via the following regression models:
Mediator models (2) where = ( 1 , 2 , . . . , ) are the direct effects of the q genetic variants; measures the indirect effects mediated by for the multiple genetic variants. Similarly ( ) ( ) measures the indirect effects mediated by ( ) , = 2,3, . . . , .
Substituting the , (2) , (3) , . . . , ( ) with the values in (2), we have
Where
Equation (3) shows that indirect effects mediated by (2) , (3) , . . . , ( ) would be absorbed by the direct effects ̃ if we only model gene . Therefore, without loss of generality, we only consider the mediation analysis for a given single gene expression level and consider the regression models below
where 1~( 0, 1 2 ), 2~( 0, 2 2 ), and we assume that 1 and 2 are independent;
otherwise their correlation would make themselves mediator-outcome confounders which violates the key assumption for mediation analysis (30, 31 
This can be conveniently solved by the intersection-union test (IUT 
Testing in the Mediator Model
Many of the testing methods for association between multiple genetic variants and the trait can be applied here. We adopt the SKAT framework, a de facto locally powerful test (36) , which accommodates large numbers of genetic variants efficiently.
Testing in the Outcome Model
The outcome model is also high dimensional with multiple genetic effects and the mediator. Classic regression models tend to fail for such models. As a solution, we employ the following mixed effects model to reduce the dimension of parameters.
{~.
We first write out the log-likelihood function for model (8) and then derive the Rao's score statistic (38, 39) for testing . Next, we apply Expectation-maximization (EM)
algorithm to obtain maximum likelihood estimate (MLE) under the null hypothesis (40, 41) . Finally, the score statistic is evaluated at MLE.
The log-likelihood for outcome is
where ≔ ( ) = 2 + 2 and 1 ≔ (1,1, … ,1) is a vector of copies of 1.
The Rao's score statistic for testing is
where
Derivations can be found in (41) . The first and second derivatives of ℓ for our model are detailed in the Supplementary Data.
Under the null hypothesis = 0, this score statistic ( ) asymptotically follows a Chisquared distribution with one degree of freedom when MLE under the null is plugged in.
This assumes at least some of the direct effects ( = 1,2, … , ) are nonzero. When there are no direct effects, the variance component 2 is on the boundary. The asymptotic Chi-square distribution works well in simulations (Supplementary Figure S1 and S2).
We leverage the EM algorithm to obtain MLE under the null. When applying EM algorithm to mixed effects model, random effects are treated as missing data. The complete data comprise the observed outcome data and random effects. The log- 
= − 2 log(2 2 ) − 1
where = ( 1 , , 2 , 2 )
Derivations for E-step and M-step can be found in (41) .
E-step of EM algorithm is
M-step of EM algorithm is
Convergence criterion for EM algorithm is
If convergence is not reached, iteration stops when the number of iterations exceeds a pre-specified large number.
As for the starting values of EM algorithm, the intercept 1 is randomly generated from uniform distribution (−1,1). And is also randomly generated from uniform distribution (−1,1). The variance components 2 and 2 are independently generated from uniform distribution (0,1).
Simulations
To evaluate the performance of SMUT in comparison with alternative methods, we carried out extensive simulations to investigate power and type-I error. We first simulated 20,000 European-like chromosomes in a 1Mb region, using the COSI coalescent model (42) to generate realistic data in terms of allele frequency, linkage disequilibrium and population differentiation. The final dataset had 23,889 SNPs in a 1
Mb region. We constructed 10,000 pseudo-individuals by pairing up the 20,000 simulated chromosomes. To evaluate power and type-I error, we generated 200 datasets with 1,000 samples each by sampling without replacement from the entire pool of 10,000 samples above. Simulations were restricted to the 2,891 SNPs with minor allele frequency (MAF) ≥ 1%.
The outcome (trait) and the mediator were generated via the following outcome model (21) and mediator model (22), respectively.
Where ∼ (2,2), ∼ (2,2), 1 ∼ (0,1), 2 ∼ (0,1).
We set = 0.2 to evaluate the performance of SMUT and alternative methods under the scenario of pleiotropy. Specifically, the shared SNPs (sSNPs) between the two models are those that influence both the mediator and the outcome trait. The outcome (or mediator) specific SNPs only contribute to the trait (or mediator). The causal SNPs are the union of the sSNPs, mediator specific SNPs (mSNPs) and outcome specific SNPs (oSNPs). We considered two scenarios in terms of causal SNP density: sparse and dense (Table 1) , with 10 and 1,000 causal SNPs respectively. The set of (10 or 1000) causal SNPs, common across the 200 datasets, were randomly selected from the 2,891 SNPs with MAF ≥ 1%. and , again fixed across the 200 datasets, were independently drawn from a normal distribution with mean and variance both being 2.
Error terms 1 and 2 were independently generated from standard normal distribution and were separately simulated for each of the 200 datasets.
In the simulations, we tested the joint mediation effects of these 2,891 SNPs on the trait 
RESULTS
Type-I Error in Simulations
We evaluated SMUT along with alternative methods in simulations. SMUT manifested error rate is 75%. This is likely due to the violation of LASSO's sparsity assumption (44) .
Assuming normality of ( = 1,2, … , ) in the outcome model may not be strictly correct when some SNPs are non-causal ( exactly zero) while others are causal. A mixture distribution would be more appropriate. But our approach gives valid tests in simulations even when the assumption may not be valid.
Power in Simulations
We assessed power only for tests with protected Type-I error, namely our SMUT and 
Robustness with Alternative Testing Strategies
As aforementioned, the true causal SNPs were drawn from common (MAF > 1%) SNPs and by default all common SNPs were simultaneously modeled and tested. Thus the set of testing SNPs include all the causal SNPs. Alternatively, we considered two other testing strategies: (1) eQTL SNPs only; and (2) SNPs with MAF  5% only. Under (1), our observations above regarding Type-I error and power remained largely the same:
namely SMUT remained valid and more powerful than alternative methods (Figures 4   and 5 ). In addition, adapted Huang et al. was more powerful using testing strategy (1) than testing all common SNPs in the default setting in most scenarios. 
Real Data Application: METSIM Dataset
The METSIM study is a population-based study with 10,197 males, aged 45-73 years, randomly selected from the population register of Kuopio town in eastern Finland (population 95,000) (45). We analyzed genotype, gene expression and phenotype data in the subset of 770 participants with gene expression measurements from subcutaneous adipose tissue (46) . The outcome of interest is plasma adiponectin levels. All METSIM subjects participated in a 1-day outpatient visit to the Clinical Research Unit at the University of Kuopio for data collection, which included an interview for their medical history and a blood sample following a 12-hour fast. Plasma was measured using the Human Adiponectin Elisa kit (LINCO Research).
Here, we tested two "positive control" loci for which our previous study (46) provided mechanistic evidences. The first locus was the adiponectin-associated GWAS locus ARL15 (with the index SNP rs6450176 being an ARL15 intronic variant), where the association might be mediated, at least in part, through altered expression of the FST gene located further (>521 kb from rs6450176) away instead of ARL15 (46, 47) . The second locus was the ADIPOQ locus, also associated with adiponectin levels.
We first extracted SNPs within ±1Mb of the corresponding genes, ARL15 union FST and ADIPOQ union ADIPOQ-AS1 for the two loci respectively. In terms of phenotypic outcome, namely adiponectin, trait levels were inverse normal transformed after adjusting for age and BMI, following our previous work (46 Table 2 ) because it required standardized genotype data which can be undefined for low frequency SNPs. SMUT and SMR both showed significant mediation effects through ADIPOQ on adiponectin: SMUT for two probesets and SMR for two probesets. For the second FST-ARL15 locus, we tested 366 SNPs with MAF  1% and adiponectin association p values < 0.01. Only SMUT detected significant mediation effects through FST (but not ARL15) on the adiponectin. These results suggest that our SMUT is more powerful for detecting genuine mediation effects.
DISCUSSION
We propose SMUT, a flexible regression based approach that tests the joint mediation effects of multiple genetic variants on an outcome through a given mediator (e.g. gene). (6, (48) (49) (50) .
Conceptually, TWAS methods are also designed to elucidate mechanisms regarding the mediation effects of multiple SNPs via gene expression on phenotypic outcome.
However, as previously mentioned, TWAS is designed for scenarios where eQTL and GWAS datasets are from two separate sets of study participants. Our SMUT method is designed for the scenario where we have genotype, mediator, and phenotype information measured in the same study subjects. Therefore, we have not directly compared with TWAS methods and deem our SMUT and TWAS useful for different data scenarios.
SMUT can be further extended in several directions. It can be extended to accommodate binary, survival, or longitudinal phenotypic outcome, given its regression based framework. We can also extend SMUT to simultaneously model multiple mediators, which may yield improved power for testing at the price of stronger modelling assumptions.
With more genotyping-based GWAS and large whole genome sequencing efforts underway, the already dauntingly large number of GWAS variants will continue to increase. Approaches generating hypotheses on the mechanisms underlying these variants are imperative. We anticipate SMUT will be a powerful tool in this post-GWAS era to help with bridging the functional gap of GWAS, prioritizing functional follow-up, and disentangling the potential causal mechanism from DNA to phenotype for a new drug discovery and personalized medicine.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR online.
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Figure 5.
Power and type-I error under alternative setting (1) when testing mediation effects using the true eQTL SNPs and the underlying truth for simulated data sets is the dense scenario in Table 1 . The meaning of x-axis and y-axis is the same as Figure 2 .
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